Leadership
As many as 700 employees reportedly dismissed from posts starting on 14 February as the culling of the federal workforce by the Trump administration’s Department of Government Efficiency reaches FDA.
Jim Jones resigna due to widespread layoffs at the agency the Trump administration’s Department of Government Efficiency imposed.
President Trump's Executive Order creating the commission names mental health and weight-loss drugs as treatments of concern. But it does not mention vaccines, which Kennedy has criticized.
Trade groups say they welcome working with Robert F. Kennedy Jr. on expanding and improving consumer access to OTC drugs and dietary supplements. White House “Department of Government Efficiency Workforce Optimization Initiative” limits filling federal agency vacancies.
A new season of HBW Insight's Over The Counter podcast kicks off with a chat about creativity in consumer health with All Creative founder and managing director Beverley Law.
A round-up of the latest exec moves: Haleon names new Southeast Asia head; Reckitt appoints Central Europe chief; and Midsona CEO to depart.
The Trump transition so far has all the hallmarks of the tech industry’s favorite management slogan, but that might not work well for biopharma companies if the FDA is one of the agencies that gets broken.
Outreach by Kennedy and the Trump Administration appears to have quelled Sen. Cassidy’s fears about oversight of vaccine regulations and safety monitoring.
During Trump’s second administration and with Republican majorities currently in both chambers of Congress, FDA may find even less support than it traditionally has for appeals for additional resources to improve compliance with the NDIN requirement. Likewise for FDA request mandatory product listing requirement for supplements available to US consumers.
“We've heard perhaps some kind of support for non-drug approaches to addressing a range of conditions,” says food and drug regulation attorney Jessica O’Connell. “For the first time in the nearly 80 years of HHS, we will have a secretary who actually sees our commodity is valuable and not just some nuisance they have to deal with,” says NPA CEO Daneil Fabricant.
HBW Insight asks consumer health experts for their views on the trends that will shape the market in 2025.
A round-up of the latest consumer health exec moves: Haleon names UK head; Kenvue appoints skin health president for APAC & LATAM; Piramal CH hires India CEO.
New details are emerging about how the administration will implement some of President Trump’s workforce shift back to mostly in-office work.
HBW Insight speaks to food supplement market experts about what manufacturers should be looking out for over the coming year.
The FDA's interim leadership takes shape, but the sense of transition chaos still lingers.
HBW Insight speaks to consumer healthcare industry associations around the globe, which offer their predictions for the year ahead.
HBW Insight speaks to leaders at US consumer health product trade groups and food and drug regulation consultants and attorneys who offer their predictions for the year ahead.
HBW Insight speaks to leaders at major consumer health manufacturers who offer their predictions for the year ahead.
A round-up of the latest European people moves: PAGB names new president; Enzymatica hires marketing & sales director; Marinomed strengthens supervisory board.
Beauty industry insiders from trade associations and attorneys specializing in marketing law and/or cosmetics manufacturing look forward to a more business-friendly FTC in the US in 2025, while they expect industry to face an increasing number of challenges at the state level. Meanwhile, the EU beauty market is hopeful it will see reduced regulations this year.